9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effectiveness and safety of milnacipran treatment for a patient with delusional disorder, somatic type taking multiple medications for concomitant physical diseases.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A 73-year-old male patient with delusional disorder, somatic type (DDST) who had a delusion of skin infestation with insects was presented. He was taking multiple medications to treat concomitant physical diseases. Milnacipran was selected as the treatment drug because of its low drug-interaction profile. Milnacipran treatment at the doses of 25 to 50 mg/d decreased the infestation delusion significantly, without an adverse effect or event suggestive of a drug interaction. The effectiveness of the drug was confirmed coincidentally by repeated recurrences and improvements after his deliberate discontinuation and restart of the drug, respectively. The present report suggests that milnacipran is effective for a patient with DDST and that this drug may be the first choice when the patient is taking multiple medications.

          Related collections

          Author and article information

          Journal
          Clin Neuropharmacol
          Clinical neuropharmacology
          Ovid Technologies (Wolters Kluwer Health)
          1537-162X
          0362-5664
          Jul 2010
          : 33
          : 4
          Affiliations
          [1 ] Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan; and daggerAkino Hospital, Tendo, Japan.
          Article
          10.1097/WNF.0b013e3181dca95e
          20386103
          a03ea939-c4c9-425e-8f07-8f5afd48929c
          History

          Comments

          Comment on this article